Pharmafile Logo

News and Press Releases

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, predictive design of manufacturing processes and...

Category: Biotechnology, Drug Discovery
Posted: May 16, 2024

Sartorius Group
info@sartorius.com
Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany

New high-throughput device to unlock the potential of advanced materials

7 May 2024 -- Birmingham, UK -- A Birmingham researcher has developed a new high-throughput device that produces libraries of nanomaterials, using sustainable mechanochemical approaches.  Dr Jason Stafford from the...

Category: BioManufacturing
Posted: May 7, 2024

The University of Birmingham
Edgbaston Birmingham, B15 2TT

How the Birmingham Drug Discovery Hub created an investment-ready ‘drug library’

18 April 2024 -- Birmingham, UK -- A novel approach to drug discovery is enabling University of Birmingham, UK, researchers to overcome the ‘valley of death’, where projects fail due...

Category: Drug Discovery
Posted: April 18, 2024

The University of Birmingham
Edgbaston Birmingham, B15 2TT

X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy 

2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....

Category: Drug Discovery
Posted: April 2, 2024

X-Chem
info@x-chemrx.com
100 Beaver Street Waltham, MA 02453

Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery

Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Programme....

Category: Drug Discovery
Posted: March 20, 2024

Semarion
info@semarion.com
Cavendish Laboratories JJ Thomson Ave Cambridge CB3 0HE UK

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics 11 March 2024 -- Dundee, UK --...

Category: Drug Discovery
Posted: March 11, 2024

Ubiquigent
services@ubiquigent.com
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK

Aston University and University of Warwick team wins £1.8m for research to aid drug discovery and sustainable chemical production

The team will engineer cells to make membrane proteins efficiently The proteins will be used for drug discovery and screening, and as catalysts in sustainable chemical production The £1.8m Engineering...

Category: Drug Discovery
Posted: February 12, 2024

Aston University
Aston University Birmingham B4 7ET UK